Hansen, F.J.* ; Mittelstädt, A.* ; Clausen, F.N.* ; Knoedler, S. ; Knoedler, L.* ; Klöckner, S.* ; Kuchenreuther, I.* ; Mazurie, J.* ; Arnold, L.S.* ; Anthuber, A.* ; Jacobsen, A.V.* ; Merkel, S.* ; Weisel, N.* ; Klösch, B.* ; Karabiber, A.* ; Tacyildiz, I.* ; Czubayko, F.* ; Reitberger, H.* ; Gendy, A.E.* ; Brunner, M.* ; Krautz, C.* ; Wolff, K.* ; Mihai, S.* ; Neufert, C.* ; Siebler, J.* ; Grützmann, R.* ; Weber, G.F.* ; David, P.*
     
 
    
        
CD71 expressing circulating neutrophils serve as a novel prognostic biomarker for metastatic spread and reduced outcome in pancreatic ductal adenocarcinoma patients.
    
    
        
    
    
        
        Sci. Rep. 14:21164 (2024)
    
    
    
		
		
			
				Pancreatic ductal adenocarcinoma (PDAC) is one of the most lethal malignancies, presenting a persisting global health burden. Neutrophils have a double-edged role in tumor progression exhibiting both pro-tumor and anti-tumor functions. CD71, also known as transferrin receptor 1, performs a critical role in cellular iron uptake and is highly expressed on proliferating cells, and especially on activated immune cells. CD71 is known to be elevated in various types of solid cancers and is associated with poor prognosis, however, the expression of CD71 on neutrophils in PDAC and its potential clinical impact is still unknown. Therefore, we analyzed CD71 on circulating neutrophils in PDAC and clinical control patients and found a significant increased expression in PDAC patients. High expression of CD71 on neutrophils in PDAC patients was associated with reduced outcome compared to low expression. CD71 on neutrophils correlated positively with the levels of proinflammatory cytokines IL-6, IFN-γ, and growth factor ligands CD40-L, and BAFF in plasma of PDAC patients. Finally, we have demonstrated that high expression of CD71 on neutrophils was also associated with an increased expression of CD39 and CD25 on circulating T-cells. Based on our findings, we hypothesize that CD71 on neutrophils is associated with tumor progression in PDAC. Further studies are required to investigate the distinct functionality of CD71 expressing neutrophils and their potential clinical application.
			
			
				
			
		 
		
			
				
					
					Impact Factor
					Scopus SNIP
					Web of Science
Times Cited
					Scopus
Cited By
					
					Altmetric
					
				 
				
			 
		 
		
     
    
        Publikationstyp
        Artikel: Journalartikel
    
 
    
        Dokumenttyp
        Wissenschaftlicher Artikel
    
 
    
        Typ der Hochschulschrift
        
    
 
    
        Herausgeber
        
    
    
        Schlagwörter
        Cd71 ; Metastatic Spread ; Neutrophils ; Pancreatic Ductal Adenocarcinoma ; Prognostic Biomarker ; Transferrin Receptor 1; Transferrin Receptor Cd71; Ifn-gamma; T-cells; Cancer; Lymphocyte; Roles
    
 
    
        Keywords plus
        
    
 
    
    
        Sprache
        englisch
    
 
    
        Veröffentlichungsjahr
        2024
    
 
    
        Prepublished im Jahr 
        0
    
 
    
        HGF-Berichtsjahr
        2024
    
 
    
    
        ISSN (print) / ISBN
        2045-2322
    
 
    
        e-ISSN
        2045-2322
    
 
    
        ISBN
        
    
 
    
        Bandtitel
        
    
 
    
        Konferenztitel
        
    
 
	
        Konferzenzdatum
        
    
     
	
        Konferenzort
        
    
 
	
        Konferenzband
        
    
 
     
		
    
        Quellenangaben
        
	    Band: 14,  
	    Heft: 1,  
	    Seiten: ,  
	    Artikelnummer: 21164 
	    Supplement: ,  
	
    
 
  
        
            Reihe
            
        
 
        
            Verlag
            Nature Publishing Group
        
 
        
            Verlagsort
            London
        
 
	
        
            Tag d. mündl. Prüfung
            0000-00-00
        
 
        
            Betreuer
            
        
 
        
            Gutachter
            
        
 
        
            Prüfer
            
        
 
        
            Topic
            
        
 
	
        
            Hochschule
            
        
 
        
            Hochschulort
            
        
 
        
            Fakultät
            
        
 
    
        
            Veröffentlichungsdatum
            0000-00-00
        
 
         
        
            Anmeldedatum
            0000-00-00
        
 
        
            Anmelder/Inhaber
            
        
 
        
            weitere Inhaber
            
        
 
        
            Anmeldeland
            
        
 
        
            Priorität
            
        
 
    
        Begutachtungsstatus
        Peer reviewed
    
 
    
        Institut(e)
        Institute of Regenerative Biology and Medicine (IRBM)
    
 
    
        POF Topic(s)
        30202 - Environmental Health
    
 
    
        Forschungsfeld(er)
        Lung Research
    
 
    
        PSP-Element(e)
        G-509400-001
    
 
    
        Förderungen
        Deutsche Forschungsgemeinschaft
    
 
    
        Copyright
        
    
 	
    
    
    
    
    
        Erfassungsdatum
        2024-10-23